罗氏计划五年内在韩国投资4.78亿美元用于临床试验 - koreabiomed.com
Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com
生物技术与制药领域的最新动态
Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com
Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition
Roche: Sustainable Operations, Supply Chains & AI in Health - Sustainability Magazine
Roche reports pivotal MS win, but deaths add to safety questions - Fierce Biotech
AI Drug Discovery: How Roche Accelerates Health Innovation - AI Magazine
Roche halts development of satralizumab for DMD bone health - Muscular Dystrophy News
Roche halts development of Enspryng in Duchenne muscular dystrophy - Fierce Pharma
Roche to stop work on bone health treatment for Duchenne - Endpoints News
Roche taps Aussie oncologist to lead research—Chutes & Ladders - Fierce Biotech
Clinical Trials - Roche
Roche to end manufacturing of key antibiotic amid EU’s generic woes - Euractiv
Paragon's latest biotech will try to slow Alzheimer's like Roche - Endpoints News
Number of Roche Group employees from 2007 to 2025 - Statista
Roche’s fenebrutinib demonstrates decade-first benefit in multiple sclerosis - European Pharmaceutical Review
Roche unveils data behind BTK inhibitor's phase 3 multiple sclerosis win in Ocrevus trial - Fierce Biotech
Genentech cut at least 489 jobs last year, new filing reveals - Fierce Biotech
Roche continues RNA return with $1.7B deal for Sanegene drug - Fierce Biotech
Roche Expands Clinical Research in Mexico, Invests MX$1.2 Billion - Mexico Business News
Roche’s 2025 profit blunted by weakened US dollar - Medical Device Network
Roche’s 2025 profit blunted by weakened US dollar - Pharmaceutical Technology